[
  {
    "ts": null,
    "headline": "ResMed Inc. stock falls Wednesday, underperforms market",
    "summary": "ResMed Inc. stock falls Wednesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=c8a5420c9ccc26fb2e6f7f8e1905e159328838e919fbcbeecfbcb4f431472d6f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756313640,
      "headline": "ResMed Inc. stock falls Wednesday, underperforms market",
      "id": 136625871,
      "image": "",
      "related": "RMD",
      "source": "MarketWatch",
      "summary": "ResMed Inc. stock falls Wednesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=c8a5420c9ccc26fb2e6f7f8e1905e159328838e919fbcbeecfbcb4f431472d6f"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why ResMed (RMD) is a Strong Growth Stock",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=134f6d29409736c7242f5b045706ffdb68c08306b52ff85bf4b11c6df6020226",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756302303,
      "headline": "Here's Why ResMed (RMD) is a Strong Growth Stock",
      "id": 136539866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=134f6d29409736c7242f5b045706ffdb68c08306b52ff85bf4b11c6df6020226"
    }
  },
  {
    "ts": null,
    "headline": "Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds",
    "summary": "Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized careSAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark study in The Lancet Respiratory Medicine projecting a significant rise in obstructi",
    "url": "https://finnhub.io/api/news?id=facfe2dbee5dcacc8df7d4a270566a25a10ce5f0a35de1a918e778f58dbd07fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756299600,
      "headline": "Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds",
      "id": 136536916,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized careSAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark study in The Lancet Respiratory Medicine projecting a significant rise in obstructi",
      "url": "https://finnhub.io/api/news?id=facfe2dbee5dcacc8df7d4a270566a25a10ce5f0a35de1a918e778f58dbd07fa"
    }
  },
  {
    "ts": null,
    "headline": "ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows",
    "summary": "ResMed is a proven dividend grower over 10 years while also having an attractive balance sheet risk profile with a low D/E ratio. Learn why RMD stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=d96b975769bac18a7240d7ceb5c32d5759c660f2ce9a0773f3fa4b0ef4e833b2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756280594,
      "headline": "ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows",
      "id": 136535676,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1689585474/image_1689585474.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "ResMed is a proven dividend grower over 10 years while also having an attractive balance sheet risk profile with a low D/E ratio. Learn why RMD stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=d96b975769bac18a7240d7ceb5c32d5759c660f2ce9a0773f3fa4b0ef4e833b2"
    }
  }
]